Request a Quote

News & Events

Scientists in search of human biospecimens can now search the iSpecimen Marketplace via Science Exchange as part of one seamless experience

Lexington, MA and Palo Alto, CA – Oct. 24, 2017 iSpecimen and Science Exchange today announced a marketplace technology integration that will allow Science Exchange users to directly search for biospecimens available in the iSpecimen Marketplace via a single user interface.

Science Exchange is the world’s leading and most secure platform for outsourced research and development (R&D) services, and the iSpecimen Marketplace is the premier online platform instantly connecting life science researchers in need of human biospecimens with the healthcare organizations that have them. By integrating these two solutions, Science Exchange users will now have access in real time to more than 25 million banked and prospectively collected specimens, including biofluids, solid tissue, and cells, all available on the iSpecimen Marketplace.

“iSpecimen shares our commitment to accelerating breakthrough scientific discovery through innovative technology,” said Elizabeth Iorns, PhD, Founder and CEO, Science Exchange. “With the seamless integration of the iSpecimen Marketplace and Science Exchange platform, our users gain direct, on-demand access to millions of human biospecimens.”

While iSpecimen has been available through Science Exchange since 2014, the new integration minimizes the time and complexity involved with specimen procurement. Additionally, the legal and compliance infrastructure in place for Science Exchange users reduces the risks often associated with biospecimen procurement. In the iSpecimen Marketplace, researchers have instant access to compliance documentation on a per specimen basis, giving researchers assurance before obtaining specimens that their requested samples were ethically sourced with appropriate regulatory oversight.

“The drive towards precision medicine is advancing the pace of research and increasing the need for biospecimens and related services,” said Christopher Ianelli, MD, PhD, Founder and CEO, iSpecimen. “The integration of the iSpecimen Marketplace into the Science Exchange environment accelerates research by giving scientists broader access to specimens from within the world’s leading platform for outsourced scientific services. We are honored to be working with Science Exchange in this way.”

Researchers interested in iSpecimen and Science Exchange can learn more and see demonstrations this week at ProcureCon Pharma in Philadelphia, where both Ianelli and Iorns will be speaking as part of a plenary panel.

About iSpecimen
Headquartered in Lexington, MA, iSpecimen is the marketplace for human biospecimens, providing researchers with the specimens they need from the patients they want. The privately held company has developed the iSpecimen Marketplace, an online platform connecting healthcare organizations that have access to patients and specimens with the scientists who need them. Proprietary, cloud-based technology enables researchers to intuitively search for specimens and patients across a federated partner network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. Researchers easily and compliantly gain access to specimens to drive scientific discovery. Partner sites gain an opportunity to contribute to biomedical discovery as well as their bottom line. And ultimately, healthcare advances for all. For more information about iSpecimen, please visit

About Science Exchange
Science Exchange is the world’s leading platform for outsourced research, providing an efficient procure-to-pay platform for ordering services from a network of more than 2,500 qualified scientific service providers, all with pre-established contracts in place that protect client intellectual property and confidentiality. The platform increases scientists’ access to innovation and improves productivity, freeing them up from the administrative tasks and delays associated with sourcing, establishing and managing service provider contracts. Additionally, the Science Exchange enterprise program enables R&D organizations to consolidate research outsourcing spend into a single strategic relationship, driving efficiency and cost savings. Since being founded in 2011, Science Exchange has raised more than $58 million from Norwest Venture Partners, Maverick Capital Ventures, Union Square Ventures, Collaborative Fund, Index Ventures, OATV, the YC Continuity Fund, and others. For more information, visit Follow the company on Twitter @ScienceExchange.